← All diseases Muscles and connective tissue

Becker muscular dystrophy

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Level of Evidence Only (35)Meta-analysis (9)Randomized trial (10)Systematic review (9)Phase 3 study (7)Clinical trial (510)Review article (203)Early study (phase 1 or 2) (27)Case description (103)Laboratory or animal study (64)Commentary or editorial (52)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (1749)

• Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy. (2018/03/20) ♡
• Detection and management of cardiomyopathy in female dystrophinopathy carriers. (2018/03/15) ♡
• RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect. (2018/03/02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients. (2018/03/01) ♡
• Detection of early nocturnal hypoventilation in neuromuscular disorders. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Eteplirsen for paediatric patients with Duchenne muscular dystrophy: A pooled-analysis. (2018/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Beware the laboratory report: discrepancy in variant classification on reproductive carrier screening. (2018/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Novel noncontiguous duplications identified with a comprehensive mutation analysis in the DMD gene by DMD gene-targeted sequencing. (2018/03/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis. (2018/03/01) ♡
• Gut Transit in Duchenne Muscular Dystrophy Is Not Impaired: A Study Utilizing Wireless Motility Capsules. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. (2018/03/01) ♡
• Concomitant hypo-hyperdontia: A rare entity. (2018/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation. (2018/02/20) ♡
• Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle. (2018/02/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. How glucocorticoids change life in Duchenne muscular dystrophy. (2018/02/03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. (2018/02/03) ♡
• Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Virtual 3D planning of tracheostomy placement and clinical applicability of 3D cannula design: a three-step study. (2018/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Outcome measures in Duchenne muscular dystrophy: sensitivity to change, clinical meaningfulness, and implications for clinical trials. (2018/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review. (2018/02/01) ♡
• Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe persistent injection site reactions after subcutaneous 2'-O-methyl phosphorothioate oligonucleotide therapy for Duchenne muscular dystrophy. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Low-level dystrophin expression attenuating the dystrophinopathy phenotype. (2018/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions. (2018/02/01) ♡
• 227(th) ENMC International Workshop:: Finalizing a plan to guarantee quality in translational research for neuromuscular diseases Heemskerk, Netherlands, 10-11 February 2017. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel point mutation affecting Asn76 of dystrophin protein leads to dystrophinopathy. (2018/02/01) ♡
• Adeno-associated virus serotype 9 mediated vascular endothelial growth factor gene overexpression in mdx mice. (2018/02/01) ♡
• The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities. (2018/02/01) ♡
• A feasibility study using solution-focused coaching for health promotion in children and young people with Duchenne muscular dystrophy. (2018/02/01) ♡
• Perioperative management of gastrostomy tube placement in Duchenne muscular dystrophy adolescent and young adult patients: A role for a perioperative surgical home. (2018/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic potential of heat shock protein induction for muscular dystrophy and other muscle wasting conditions. (2018/01/19) ♡
• (1) H NMRS of carnosine combined with (31) P NMRS to better characterize skeletal muscle pH dysregulation in Duchenne muscular dystrophy. (2018/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early involvement of the supinator muscle in Duchenne muscular dystrophy. (2018/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis. (2018/01/01) ♡
• Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antisense oligonucleotides: the next frontier for treatment of neurological disorders. (2018/01/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy. (2018/01/01) ♡
• 226(th) ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands. (2018/01/01) ♡
• Correlating motor unit morphology with bioelectrical activity - A simulation study. (2018/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment. (2018/01/01) ♡
• ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. (2018/01/01) ♡
• Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy. (2018/01/01) ♡
• Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Subcellular Targeting of Nitric Oxide Synthases Mediated by Their N-Terminal Motifs. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities. (2018/01/01) ♡
• α-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Disturbed Ca(2+) Homeostasis in Muscle-Wasting Disorders. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Review of Recent Patents and Developments in Skeletal Muscle Regeneration. (2018/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy (2018-12-21) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.